Sign in
CompletedNo phase

Salivary and Serum Leptin Levels in Oral Lichen Planus Patients: A Case-control Study.

Key facts

Who runs it
Cairo University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
78 people enrolled
Started
30 Dec 2023
Ended
30 Dec 2024
Type of study
Observational, 2 groups
Treatments tested
  • Leptin
Record updated
30 March 2025

Who can take part

Age
30 years to 70 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Ages for both sexes fall between 30 and 70
  • Symptomatic OLP has been diagnosed clinically and verified histologically
  • Participants who sign a written consent form after being fully informed about the study

Who cannot take part

  • Treatment with a systemic or locally administered systemic medication within the previous three months before the commencement of the research
  • Patients who have been diagnosed with a malignant tumor or tumors
  • Patients now taking or who have just stopped taking an NSAIDs (both steroidal and non steroidal) for pain or inflammation
  • Women who are expecting or nursing
  • Inmates, the mentally ill, the elderly, etc, all fall into this category

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to evaluate the levels of leptin in both saliva and serum samples of patients diagnosed with oral lichen.

The 2 groups in the trial

  • Oral lichen planus patients

    Assessment of salivary and serum leptin levels

    Treatment: Leptin

  • Healthy control group

    Assessment of salivary and serum leptin levels

    Treatment: Leptin

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Salivary and Serum Leptin Levels in Oral Lichen Planus Patients: A Case-Control Study.
Record updated
30 March 2025